Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis

被引：17
作者：
Kleiter, I
Hans, VH
Schuierer, G
Marienhagen, J
Hau, P
Schütz, H
Bogdahn, U
Steinbrecher, A
机构：
[1] Univ Regensburg, Dept Neurol, D-93042 Regensburg, Germany
[2] Univ Regensburg, Inst Neuroradiol, D-93042 Regensburg, Germany
[3] Univ Regensburg, Dept Nucl Med, D-93042 Regensburg, Germany
[4] Univ Bonn, Inst Neuropathol, D-5300 Bonn, Germany
[5] Stadt Kliniken Frankfurt Main Hochst, Dept Neurol, Frankfurt, Germany
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2004年 / 75卷 / 09期
关键词：
D O I：
10.1136/jnnp.2003.024653
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Idiopathic hypertrophic chronic pachymeningitis (IHCP) is characterised by inflammatory fibrotic thickening of the dura mater. Long term management is controversial. A 28 year old man with craniospinal IHCP and prominent lymphocytic meningitis is reported. Cerebrospinal fluid and histological examination suggested a CD4+ T cell driven process and B cell stimulation. After surgical, tuberculostatic, and immunosuppressive treatment failed to control the progressive meningeal hypertrophy, causing severe headache and neurological disability, the disease process eventually abated with intraventricular cytarabine treatment.
引用
收藏
页码：1346 / 1348
页数：3
相关论文
共 12 条
[1]   MULTIFOCAL FIBROSCLEROSIS WITH HYPERTROPHIC INTRACRANIAL PACHYMENINGITIS [J].
BERGER, JR ;
SNODGRASS, S ;
GLASER, J ;
POST, MJD ;
NORENBERG, M ;
BENEDETTO, P .
NEUROLOGY, 1989, 39 (10) :1345-1349
[2]  
Bohuslavizki KH, 2001, J NUCL MED, V42, P1057
[3]   Combined therapy of corticosteroid and azathioprine in hypertrophic cranial pachymeningitis [J].
Choi, IS ;
Park, SC ;
Jung, YK ;
Lee, SS .
EUROPEAN NEUROLOGY, 2000, 44 (04) :193-198
[4]   Idiopathic hypertrophic pachymeningitis: A report of two patients and review of the literature [J].
Dumont, AS ;
Clark, AW ;
Sevick, RJ ;
Myles, ST .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2000, 27 (04) :333-340
[5]   Idiopathic hypertrophic cranial pachymeningitis: Clinicoradiological spectrum and therapeutic options [J].
Hatano, N ;
Behari, S ;
Nagatani, T ;
Kimura, M ;
Ooka, K ;
Saito, K ;
Yoshida, J .
NEUROSURGERY, 1999, 45 (06) :1336-1342
[6]   CRANIAL PACHYMENINGITIS OF UNKNOWN ORIGIN - A STUDY OF 7 CASES [J].
MASSON, C ;
HENIN, D ;
HAUW, JJ ;
REY, A ;
RAVERDY, P ;
MASSON, M .
NEUROLOGY, 1993, 43 (07) :1329-1334
[7]  
Pittella JEH, 2001, BRAIN PATHOL, V11, P261
[8]   FLOW-RATE OF CEREBROSPINAL-FLUID (CSF) - A CONCEPT COMMON TO NORMAL BLOOD-CSF BARRIER FUNCTION AND TO DYSFUNCTION IN NEUROLOGICAL DISEASES [J].
REIBER, H .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 122 (02) :189-203
[9]   Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region [J].
Voller, B ;
Vass, K ;
Wanschitz, J ;
Machold, K ;
Asenbaum, S ;
Hoberstorfer, M ;
Auff, E .
NEUROLOGY, 2001, 56 (01) :107-109
[10]   Aspecific headache during 13 years as the only symptom of idiopathic hypertrophic pachymeningitis [J].
Wouda, EJ ;
Vanneste, JAL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :408-409
12